Every publication below is separated by evidence type, research scope, and interpretation limits, with a direct link to the original record.
Educational bibliography only. Publications do not validate products sold by Subversion RX and are not dosing guidance, instructions for use, or medical advice. Laboratory materials are not for human or veterinary use.
Study 01
Human phase 3New England Journal of Medicine · 2021
What researchers examined
A randomized, double-blind phase 3 trial evaluating a GLP-1 receptor agonist in adults.
How to interpret it
A phase 3 trial can provide comparatively strong evidence for the population, intervention, dose, and endpoints studied. It does not automatically generalize to other products, populations, or uses.
Study 02
Human phase 3New England Journal of Medicine · 2023
What researchers examined
A large randomized outcomes trial in adults with cardiovascular disease and overweight or obesity without diabetes.
How to interpret it
A phase 3 trial can provide comparatively strong evidence for the population, intervention, dose, and endpoints studied. It does not automatically generalize to other products, populations, or uses.